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cancers and is associated with multifocal and contralateral breast
involvement. The National Institute of Clinical Excellence (NICE) guidelines
(2009) recommended the use of Magnetic Resonance Imaging (MRI) in the
preoperative assessment of ILC. This study aims to assess compliance with
guidelines in two District General Hospitals and the utility of MRI in the
investigation of ILC.
Methods: All cases of ILC between 2011 and 2013 were retrospectively
identiﬁed from the pathology database and their breast imaging ﬁndings
were reviewed.
Results: 107 patients had ILC, of these 41 hadMRI preoperatively (38%). MRI
upgraded mammography/ultrasound diagnoses in 8 patients (19.5%). MRI
showed multifocal disease in 13 patients (31.7%) occult on ultrasound/
mammogram, with these patients undergoing mastectomy. MRI showed a
contralateral lesion in 9 patients, 4 (9.8%) of which were ILC (5 benign) with
these patients having bilateral surgery. MRI also downgraded 4 (9.8%) pa-
tients to unifocal disease with reported multifocal appearances on
mammography/ultrasound, andMRI ﬁndings were conﬁrmed histologically.
Conclusions:MRI is highly accurate in the diagnosis of bothmultifocal and
contralateral disease in ILC and should be undertaken in all such cases
preoperatively assuming no contraindication.
0530: RATE OF RE-INTERVENTION FOLLOWING BREAST CANCER TREAT-
MENT WITH THERAPEUTIC ROUND BLOCK MAMMOPLASTY: 7 YEARS
SINGLE CENTRE EXPERIENCE
Jason On*, Elaine Yeap, Shailesh Chaturvedi. Aberdeen Royal Inﬁrmary,
Aberdeen, UK.
Introduction: Wide local excision has been the procedure of choice for
breast-conserving surgery in patients with breast cancer. This can
sometimes result in less than an ideal cosmetic outcome for the patient
such as loss of volume in the breast. Therapeutic round block mammo-
plasty (RBM) is a technique that can be used to improve these cosmetic
outcomes. The aim of this study is to look at the need for re-intervention
following RBM.
Methods: Tumour size, grade and other patient factors were collected in
conjunction with the outcome following RBM from the period between
September 2006 and October 2013.
Results: 54 eligible patients were included in this study.10 patients (18.5%)
had pathology results of at least a single margin involvement or a margin
clearance of <1mm. 9 patients had invasive ductal carcinoma and 1 with
invasive lobular carcinoma, all of grades 2 and 3. The average tumour size
is 30.1mm. 6 patients subsequently had a second procedure, 3 each had
mastectomy and re-excision of margins. Therefore, the overall risk of re-
intervention is approximately 11% following RBM.
Conclusion: Round block mammoplasty should be considered as an
alternative for patients suitable for breast-conserving surgery as it has an
acceptable rate of re-intervention.
0652: VENOUS THROMBOEMBOLISM PROPHYLAXIS IN BREAST SUR-
GERY e WHAT ARE WE DOING?
Jake Sloane*, Sophie Helme, Jennifer Hu. St Bartholomew's Hospital, London,
UK.
Introduction: In breast surgery there is a balance of risk between venous
thromboembolism (VTE) and post-operative haematoma. The NICE
guidelines (2010) state that all cancer surgery patients should be given
mechanical and pharmacological prophylaxis unless contraindicated. In
the absence of national guidelines speciﬁc to Breast surgery we sought to
ascertain what current practice is within the UK.
Methods: Aweb-based survey was sent to surgeons within the 199 Breast
Units in the UK.
Results: Responses were received from 67 units. 33% give LMWH to day-
case patients and 72% to overnight patients. 27% use LMWH for high-risk
patients only. Pre-operative LMWH is given routinely in 11% and in high-
risk patients, 33%. Only 3% give LMWH post discharge. Surgery type in-
ﬂuences whether patients receive LMWH - over 90% for complex recon-
structive cases and 50% for wide local excisions. 67% of units use Local
Trust Guidelines for General or Breast Surgery, 33% are guided by indi-
vidual surgeon preference.
Conclusion: There is a wide variation in VTE prophylaxis within breast
units. In over 1/3 of units, there are no local or national protocols followed.We suggest a need for national guidelines speciﬁc to Breast Surgery to help
guide best practice.
0661: RESECTION MARGINS IN BREAST CONSERVING SURGERY. LESS IS
MORE
Andrew McDougall*, Ahmed Hamad. Mid Cheshire Hospitals NHS
Foundation Trust, Crewe, Cheshire, UK.
Introduction: Re-excision is performed in patients with early stage breast
cancer associated with close resection margins. Re-excision of margins in
breast-conserving surgery (BCS) imposes psychological, cosmetic and
economic burdens and may delay adjuvant therapy. There is lack of
consensus regarding what is to be considered adequate margins. The aim
of this study is to critically appraise current evidence on management of
close margins after BCS.
Methods: A literature review was done using PubMed and Google Scholar
search engines using key words and phrases including: “breast”, “cancer”,
“invasive”, “wide local excision” and “margins”. Papers published since the
year 2000 were considered.
Results: Forty-seven publications were identiﬁed. Substantial variations
exist in practice. The margin of normal tissue that signiﬁcantly reduces the
risk of local recurrence remains undeﬁned. Tumour biology plays a more
signiﬁcant role. With adjuvant therapy, close margins were not associated
with an increased risk of local recurrence compared to wider margins.
Conclusions: Decisions regarding resection margins in BCS should be
made in the context of tumour biology, adjuvant treatment and cosmetic
outcomes. With adjuvant therapy, wider margins do not reduce local
recurrence compared to close margins. Additional studies and a consensus
on management of surgical margins are needed.
0755: AXILLARY ULTRASOUND IN BREAST CANCER e A DGH EXPERI-
ENCE
Abraham Joel*, Shantanu Rout, Neal Ormsby, Huw Garrod, Avier Chong,
Shabbir Poonawala. Arrowe Park Hospital, Wirral, UK.
Introduction: Prognosis in breast cancer is primarily determined by
staging the axilla most commonly by sentinel lymph node biopsy (SLNB).
We aimed to look at our practice in theWirral breast unit and compare it to
national standards.
Methods: Retrospective analysis of all patients undergoing axillary ultra-
sound (US) at the Wirral breast unit over a 1 year period was undertaken.
Data was collected from the radiology database and patient records.
Results: 371 patients with breast cancer underwent axillary US that was
graded from A1 (normal) to A5 (likely malignant nodes). Of the 203 axillae
that were initially coded normal, 13.7% went on to have axillary node
clearance (ANC) and half had histological evidence of axillary nodal spread.
In 42 patients the axillawas coded A3 of which 26.1% needed clearance and
19% had histological evidence of disease. In A4 axillae 30% underwent ANC
of which 21.7% were positive and in A5 axillae 47.7% needed ANC of which
41% had disease.
Conclusions:AxillaryUS is themost appropriate initial test for assessing the
axilla. Pick up rates in our unit compare favourablywith national standards.
However there still remains a signiﬁcantly high false positive rate.
0800: DOES THE IMPLEMENTATION OF AN ENHANCED RECOVERY PRO-
GRAMME IMPACT ON POST-OPERATIVE OUTCOMES IN POPULATIONS
WITH SIGNIFICANT COMORBIDITY AND SOCIAL DEPRIVATION?
Ee Von Woon*, Pang Long Wong, Juliette Murray. Wishaw General Hospital,
Lanarkshire, UK.
Introduction: In Lanarkshire (Scotland), the Enhanced Recovery Pro-
gramme (ERP) was introduced inWishawGeneral Hospital in 2012 but has
yet to be extended to neighbouring Monklands Hospital. We audited the
impact of the ERP between these district general hospitals, which are both
in areas of signiﬁcant social deprivation.
Methods: All patients who underwent breast surgery from August 2012 to
August 2013 inclusive were identiﬁed from a prospectively collected
electronic database. Parameters analysed included length of postoperative
stay, rate of post-operative complications and re-admissions. The relative
social deprivation of patients was calculated with the Scottish Index of
Multiple Deprivation 2012.
Results: 294 and 152 patients underwent 336 and 161 breast operations in
Wishaw and Monklands respectively. The mean postoperative stay and
postoperative complications was signiﬁcantly higher in Monklands
compared toWishaw (p<0.05). There was no signiﬁcant difference in rates
of readmissions, A&E visits or reoperation (p>0.05). In patients with
complications, there was no signiﬁcant difference in their deprivation
status.
Conclusions: The ERP is a safe and effective protocol for breast surgery
patients with low complication rates and its implementation halved the
inpatient admission time in our cohort. The savings derived from this
would outweigh the running costs of the ERP.
0876: PREDICTORS OF LYMPH NODE METASTASIS IN LOCALLY
ADVANCED BREAST CANCER: WHAT TO DO WITH MICROMETASTASES?
Hannah Vaughan-Williams*, Michael Rees, Rory Kokelaar,
Pawel Pietrzsak, Louise Da Silva, Sumit Goyal. The Breast Centre,
Llandough Hospital, Cardiff, UK.
Introduction: Management of the axilla in breast cancer patients is
becoming increasingly complex. We assessed the surgical management of
breast cancer in a single centre and identiﬁed factors predictive of lymph
node metastasis.
Methods: A prospectively maintained database (January 2009 e
December 2011) was used to assess patients undergoing breast cancer
surgery involving axillary staging with Sentinel Lymph Node Biopsy
(SLNB). Primary outcomes were factors predictive of positive sentinel
lymph node at index procedure. Secondary outcomes were factors pre-
dictive of further lymph node metastases at subsequent axillary node
clearance (ANC).
Results: 456 female patients (age 29-90) were included, of whom 70
(15.4%) had at least one positive node at SLNB. Of these, 17 (32%) had
micrometastases alone while the remainder had evidence of macrometa-
stasis. 60 patients (85.7%) received ANC, of whom 18 (30%) had evidence of
further positive nodes. No patients with micrometastases alone at SLNB
had evidence of further positive nodes at ANC. On multivariate analysis,
factors predictive of positive SLNB were tumour size (p<0.01) and vascular
invasion (p<0.001). The only factor predicting further node involvement at
ANC was presence of macrometastasis at SLNB (p¼0.036).
Conclusions: Our results suggest that ﬁnding micrometastases alone at
SLNB may not necessitate ANC.
1057: IS THERE STILL A ROLE FOR BONE SCINTIGRAPHY IN PATIENTS
WITH BREAST CANCER SELECTED FOR SYSTEMIC STAGING IN THE ERA
OF MULTI-DETECTOR CT?
S.R. Tee*, D.P. McCartan, J. Rothwell, J. Geraghty, D. Evoy, C.M. Quinn,
R.S. Prichard, S. Skehan, A. O'Doherty, E.W. McDermott. St Vincents
University Hospital, Dublin, Ireland.
Introduction: Approximately 7% of women will have distant metastases
when presenting with breast cancer. The aim of this study was to evaluate
the additional diagnostic yield from bone scintigraphy in patients with
newly diagnosed breast cancer undergoing CT staging of the thorax,
abdomen and pelvis.
Methods: Patients with newly diagnosed breast cancer who underwent
systemic staging with CT-TAP and bone scintigraphy were included. Results
of biopsy and staging investigations were correlated. Criteria for staging
included: Locally advanced or inﬂammatory breast cancer, Neoadjuvant
therapy, Biopsy proven axillary nodal metastases on US axillary staging, Pa-
tients undergoing mastectomy, Symptoms suggestive of metastatic disease.
Results: 135 patients (median age 59) underwent systemic staging in
2012. Seventeen patients (13%) had distant metastases. Four patients (3%)
hadmetastases tomore than one organ on CT. Of the 13 (10%) patients with
one metastatic site, 2 (1%) had liver metastases and 5 (4%) had lung me-
tastases only. Six patients (4%) had bone metastases and only one of these
involved a bone (subtrochanteric femur) metastasis not seen on CT-TAP.
CT-TAP alone would have resulted in a false negative rate of 0.7%.
Conclusions: In patients with newly diagnosed breast cancer selected for
systemic staging, multi-detector CT is a satisfactory stand-alone in-
vestigation.
1098: THE ROLE OF TSG101 IN EXOSOMAL COMMUNICATION IN TRIPLE
NEGATIVE BREAST CANCER TUMOURS AND ITS POTENTIAL AS A
CHEMOTHERAPEUTIC TARGET
Shiva Sharma*,1, Luke Gubbins 1, Karolina Weiner-Gorzel 1,
Jeremy Simpson 3, Malcolm Kell 4, Amanda McCann 2. 1UCD, School of
Medicine and Medical Science, Dublin, Ireland; 2UCD, Conway Institute for
Biomolecular and Biomedical Research, Dublin, Ireland; 3UCD, School of Biology
and Environmental Science, Dublin, Ireland; 4Department of Surgery, Mater
Misericordiae University Hospital, Dublin, Ireland.
Introduction: TSG101 is an essential protein involved in the sorting and
trafﬁcking of cell components destined for cellular processing, degradation
or cellular release, and is integral to exosome production and release.
Exosomes have the ability to carry transcriptional information and transfer
information.
Results: BT-549 TNBC cells were more sensitive to the chemotherapeutic
drug Paclitaxel compared to MDA-MB-231 TNBC cells which were more
chemoresistant. Western Blot analysis demonstrated TSG101 levels were
higher in MDA-MB-231 and remained constant after 24 and 48 hours
treatment, while the more Paclitaxel sensitive BT-549 showed decreased
TSG101 levels, which decreased after 24 and 48 hours of Paclitaxel
treatment. Using a siRNA-knockdown of TSG101, NanoSight particle
analysis revealed the size and numbers of exosomes released by these
cell lines differed. Immunohistochemical analysis of 85 breast cancer
cases on TissueMicroArray established strong cytoplasmic staining of
TSG101 in 20% of cases, while 53% of tumours demonstrated none/weak
staining of TSG101.
Conclusions: We conclude that TSG101 is differentially expressed in the
TNBC in vitro and that expression levels are inﬂuenced by Paclitaxel
treatment, and siRNA-knockdown of TSG101 impedes the release of exo-
somes suggesting that high levels of TSG101 may provide a mechanism for
the dissemination of the malignant phenotype in recipient cells.
1113: WIDE LOCAL EXCISION UNDER LOCAL ANAESTHETIC FOR EARLY
BREAST CANCER: A SURGICAL OPTION FOR THE MEDICALLY UNFIT
Deepak Selvakumar*, Christopher Davies, Rahul Chotai,
Muhammad Asad Parvaiz, Brian Isgar. Department of Breast Surgery, New
Cross Hospital, The Royal Wolverhampton NHS Trust Hospitals,
Wolverhampton, UK.
Introduction: The mainstay of treatment for early breast cancer is surgery.
However for elderly and medically unﬁt patients treatment can be chal-
lenging. We look at the use of wide local excision (WLE) performed under
local anaesthetic (LA) compared to primary endocrine therapy (PET) in this
group of patients.
Methods: All breast cancer patients aged 50 and above, receiving non-
standard therapy (WLE under LA or PET), in the last 5 years were included.
We comparedmortality and follow-up times between these two treatment
groups.
Results: A total of 85 patients were seen, 26were included in theWLE under
LA group and 59 in the PET group. There was no signiﬁcant difference in
patient age (median age 85 and 83 respectively). Patients havingWLE under
LA had signiﬁcantly lower mortality (19%, p<0.05) and longer follow-up
time (35 months, p<0.05) compared to the PET group. The primary reason
for non-standard therapy in both groups was due to poor medical ﬁtness.
Conclusion: Selection to non-standard therapy should be made using a
combination of preoperative assessment and detailed discussion with
patients. Within this subset the use of WLE performed under LA can be a
successful treatment option for motivated patients with intact cognitive
function.
1125: EFFICACY OF POST-OPERATIVE PAIN CONTROL WITH THE HELP
OF PATIENT CONTROLLED WOUND SOAKERS (CONTINUOUS INFILTRA-
TION OF LOCAL ANAESTHETIC INFUSION) FOLLOWING BREAST RECON-
STRUCTION
Tom Pampiglione*, Khurram Siddique, Iman Azmy. Chesterﬁeld Hospital,
Chesterﬁeld, UK.
Introduction: Poor pain control following breast reconstruction has been
shown to increase the patient morbidity & the length of stay. Intravenous
narcotic analgesia has signiﬁcant side effects. To prospectively assess the
efﬁcacy of pain control with patient controlled wound soakers.
Methods: A prospective cross-sectional study including all breast re-
constructions with patient controlled wound soakers performed between
Apr12- Mar 13 was conducted.
Results: A total of 36 patients with the age of *49 (37-74) were included.
Procedures included expander/implant reconstructions with dermal sling
or Strattice 72%, LD ﬂaps 16% etc. Over 70% of patients experienced either
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